{"name":"MC2 Therapeutics","slug":"mc2-therapeutics","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"oncology","drugs":[{"name":"MC2-25 cream","genericName":"MC2-25 cream","slug":"mc2-25-cream","indication":"Other","status":"phase_2"},{"name":"Challenge: Application of MC2-01 Cream, irradiation","genericName":"Challenge: Application of MC2-01 Cream, irradiation","slug":"challenge-application-of-mc2-01-cream-irradiation","indication":"Other","status":"phase_1"},{"name":"Challenge: Control, irradiation","genericName":"Challenge: Control, irradiation","slug":"challenge-control-irradiation","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"MC2-25 cream","genericName":"MC2-25 cream","slug":"mc2-25-cream","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Challenge: Application of MC2-01 Cream, irradiation","genericName":"Challenge: Application of MC2-01 Cream, irradiation","slug":"challenge-application-of-mc2-01-cream-irradiation","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Challenge: Control, irradiation","genericName":"Challenge: Control, irradiation","slug":"challenge-control-irradiation","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxOMFJHUk9hWF95VjVYVkpXWndmLXdpdXJHYTkxZjNfQmZMQXE1a012YXltY0Yxc2ZOOF9ScUhIOTcxZGpJZmk2aVNia1lRME1ieVAtdDBNV2s2NzQtWWZWUVVscUZCakVhR3d4NFhCNnVZcWxhbFlpaURiNUthX3kzN2RNS0xOS2p2RXJaN29ROFVWWTg?oc=5","date":"2025-12-18","type":"regulatory","source":"Yahoo Finance","summary":"Knight Therapeutics Announces Health Canada Approval for WYNZORA® to Treat Psoriasis Vulgaris - Yahoo Finance","headline":"Knight Therapeutics Announces Health Canada Approval for WYNZORA® to Treat Psoriasis Vulgaris","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxNMldJM0FhMThaMlR2RHZmV0kxejlRUWViMHNsd3hRS1JFOHB1cW54VTJRZ2pCZGJoSGtSMVllR2J1d2g2VzctSlUxQnRnZ0pZckVJT3dXc1MwUmZpU0U0U0xxWGlIVTFPbUJIR0U0Q3NVUy05c19BVFM0bXlYdF9Gbnp6akdLMEJaLW5YcDFKTGh0MExH?oc=5","date":"2025-05-30","type":"pipeline","source":"Fierce Biotech","summary":"20-year Novo vet lands first CEO role—Chutes & Ladders - Fierce Biotech","headline":"20-year Novo vet lands first CEO role—Chutes & Ladders","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxOaFZlWUhOZEw2LUtpZ3VJZU1PcmtvOWx5WVpyM29DTWx6RGd2ZnRRYWYzNmhrSDQyS21ZWTY0Q011SV9wS0JJVHFpRXJhMHloQTNLUlZvTS1WZVpPekluMjZCZGUyaS1RZ1VpRXZVZTlwdHFOY0F5bGJucExaSjhyRmN2MVY3Z0FPSUxVdFF3SlBXc09WZjhyeDNB?oc=5","date":"2025-05-29","type":"pipeline","source":"Medical Marketing and Media","summary":"The Escalator: Acadia Pharmaceuticals, Indivior, Takeda and more - Medical Marketing and Media","headline":"The Escalator: Acadia Pharmaceuticals, Indivior, Takeda and more","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxPVFRMM1NrcG5jVGw4SnFOVTR6MlhTX0ZUdlM5QWI4VzhKNk1hdkJnM05UdGwxRDgyWmpjX0duR3h2dGs2b2wxa0owcmtxOE1LMXlibnBrai1lbzhsWXhWTzZDZlRsOTBCZmVkQVEySHd1ZGdpWEw2UFZZQ3JIbGoyOUhFRU9XRmljZFZsTzdWZld2QQ?oc=5","date":"2025-05-27","type":"pipeline","source":"Pharmafile","summary":"MC2 Therapeutics appoints Trine Ahlgreen as new CEO - Pharmafile","headline":"MC2 Therapeutics appoints Trine Ahlgreen as new CEO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxQZHVteElyNHNVYzZXNnlNamZzM21rc0x1QUdrWDJuR2JwTEIzODk4akV5cVQ5N25RWDl5Zk9HN0pyMzVkcEhUUmM2R0ZJWWVKa2E1Wl9oZjYxWlYzVGkyb2hKTVlXS1hPUWhEaVlyTUxTa0xubGMzNHpENXV6X0U5UDlDQ2Vsd1ZlNmVtSEI4cndYcmVYRjl0RU9qaHlFUGxSb1VycTZJZkVpMzlDd1V6VW5ud2ZpR2JrdFlEM09yNWNiX1B5?oc=5","date":"2024-11-18","type":"regulatory","source":"ChemAnalyst","summary":"Endo Partners with Paladin Pharma to Launch Wynzora Cream in Canada - ChemAnalyst","headline":"Endo Partners with Paladin Pharma to Launch Wynzora Cream in Canada","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1wFBVV95cUxOZHdMNmRJdm1DMUhTaFZqOERLdWd3SVUyX0t4T0NQbHFfMHpQNVp0Rmo4dl9vZkhBSy0za0ZBQnloeUloS0VZRlJXVF90QlU2Z05EOXNNRlRnTlhMUnpnVUo2MnMxR0dFZ0VtMURNZHloS0hsaERWQndpT0tLZDdWaC1UVWZ0SkxmUEluZms3OEJrVTdBeXFFUFVfeTI4UUNOSDMtNUtVYWY0Nm1IWmk3TUVoNWNReExKZTQxYW5CdnBYTldfcmdaYXAtYmtSRklfYnJyMUtFbw?oc=5","date":"2024-11-15","type":"pipeline","source":"PR Newswire","summary":"Endo Announces Agreement for Paladin Pharma to Commercialize Wynzora® Cream in Canada - PR Newswire","headline":"Endo Announces Agreement for Paladin Pharma to Commercialize Wynzora® Cream in Canada","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxPOU10T0ZndWN1VUZYcE9OVy1VR2JzcGtZSlpXamRIY0cxS2FNRlZTWEllNUdJSmFGUDMzZGVxNlpaSG5qOFk4cTl5Y2pnNUZHWEtyOGFaQVlDNGJmalY4Z2dYWnlScGVxazA4eWpXMU1ZT3p5LTlvbU1iUVZTMnp3TEhLQ3JVb0hKc1djOGJ0cnBDRzZuQnEwZDlHZjN3VmVzelBFRnlYWGhyRDkyWTNRWg?oc=5","date":"2024-09-16","type":"pipeline","source":"BioWorld News","summary":"Omass Therapeutics describes new melanocortin MC2 receptor antagonists - BioWorld News","headline":"Omass Therapeutics describes new melanocortin MC2 receptor antagonists","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxOaHNiQW5neHZQeHBzUVEzd2duZzlDd3AwX0JyaWlDY1pYZFhtek5yZHM5Q1U5NUdxMUdRQzRDS2I4bm5ySHlFT29McUxIS1lFS1huMnFaelhuZk11UVZKZTVtc2RITHRMcS1acTJOdXUwb1hyOFdXdl9GQS0xYXlqdDFhMHZkRmRmTF95Z28tVnkxMWhwMER5MWhPQ29TVGVHSEVzejVHWkdDUDBET2FmUnIxQWNmRk9QbHE4UDZlVmxXQQ?oc=5","date":"2024-03-13","type":"deal","source":"BioPharma APAC","summary":"Hyphens Pharma licenses Wynzora® Cream for ASEAN countries from MC2 Therapeutics - BioPharma APAC","headline":"Hyphens Pharma licenses Wynzora® Cream for ASEAN countries from MC2 Therapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxOWlRCYjFZcWlleUZ5amxkazVuOGFscVBDeVhETDFJQTZRd2JGdmdWWDBxQVBGdFNqejVBNnNIYTRwS2pwMWVlQ05MelNDR3NKUG1PbldzZURlOHBPZEkzRjkwZjBJcklMX0FSRDZEWEdKai1EMlMyV0ZfbEMzeXhCOUozU2hzZ1dlZWlTcEFPc3E0QlRKQmx1Skc4WlM4TE1IMXVBYlRFYw?oc=5","date":"2024-03-12","type":"deal","source":"BioSpace","summary":"Hyphens Pharma licenses Wynzora® Cream for ASEAN countries from MC2 Therapeutics - BioSpace","headline":"Hyphens Pharma licenses Wynzora® Cream for ASEAN countries from MC2 Therapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxNT2NpcTl5ZE45dU5fSlZhSUdGM2tYWTFJMFZMdExhUHJiTUlkVXA2UWFnS0REcGNzSDNtUy1lOUV1ODRZMmVSN0FzMTlnaHV5Q2Y3VElvQndObEpIQW5hUm45U3hpWjV5dTRQTlhVNUN4bGNqLU5ISFNJa0ROSEo1V0I4bw?oc=5","date":"2023-09-01","type":"deal","source":"Pharmaceutical Technology","summary":"Huadong enters licence deal for MC2 Therapeutics’ Wynzora cream - Pharmaceutical Technology","headline":"Huadong enters licence deal for MC2 Therapeutics’ Wynzora cream","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAJBVV95cUxOdlFUNkZSUXlfT2l1XzE0RHhwTDVLeDhmQ3NfT1p1WVpkQ0tVdmFXSlplLXhlV0xGam43OEdzRlBxdHNZQzlDbDZzMG9GYjFVNExwUXlBNzJ1NUxXUjQ0QU45My1sckpVZDFZQzF3ZllIenNzMm1Ld3M0RDVhVnZOdGlGSEhraS1ydTZMVUJHR3RJQUNCclM3R0U1QU5mLUNCWUZqd2h1b3RZSUREVVhhMFdXbDZNNnNSdFUtdXpTMzdfOVByRThGQkxScG9DTHRoTkVhR2I4Z0ktaFRydmxZM3hlQ29XSlRsdk5aUVJhaC1hVUxWVktaZU11SnRubTR0MjV4dTFWZzVfZnN0QTBhTllHOERzLUJnTl9ielVSOWw?oc=5","date":"2021-02-17","type":"deal","source":"Odessa American","summary":"Almirall and MC2 Therapeutics enter a License, Collaboration and Commercialization Agreement for European Rights to Wynzora® Cream for treatment of Plaque Psoriasis - Odessa American","headline":"Almirall and MC2 Therapeutics enter a License, Collaboration and Commercialization Agreement for European Rights to Wynz","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxOMkFhQXAzdzB4NXhWZnZoOUVvVF8wTVBpUXNnQ29nOThVdTNIUHNaZWRoWk9hb2JsWFNJM0pHZ0t6MVVqdlJvVjBEUGhYbWpnVEIwNnpEU0VxRnJUSUJzRzVOSXhrRFlMNXQ3LW9aTE11b3VjMndKUXJpQy1wbnFWeWV0VFB0YjFlZXhPcVNzaWRmdDgzMDJvMmgwaU9qSG9iUl9HVzRNUi1vSXJEUDNqX2FBelI?oc=5","date":"2020-09-02","type":"regulatory","source":"Dermatology Times","summary":"MC2 Therapeutics collaborates EPI Health on newly approved psoriasis topical - Dermatology Times","headline":"MC2 Therapeutics collaborates EPI Health on newly approved psoriasis topical","sentiment":"positive"}],"patents":[],"drugCount":3,"phaseCounts":{"phase_2":1,"phase_1":2},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}